The elusive but pathogenic peptidoglycan of chlamydiae

European Journal of Inflammation

Volumn 11, Issue 1, 2013, Pages 257-260

  Di Pietro, M ^a   De Santis, F ^a   De Biase, D ^b   Sessa, Rosa ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Chlamydia; Cp0259; Peptidoglycan; Persistent forms

Indexed keywords

AMINOTRANSFERASE; DIAMINOPIMELIC ACID; DIAMINOPIMELIC ACID AMINOTRANSFERASE; PEPTIDOGLYCAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL CELL WALL; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CHLAMYDIA; ENZYME SYNTHESIS; GENE EXPRESSION; IN VITRO STUDY; NONHUMAN; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

EID: 84879990055     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727X1301100126     Document Type: Article

References (29)

1. Wyrick PB. Chlamydia trachomatis persistence in vitro: an overview. J Infect Dis 2010; 201:S88-95.
2. Dlugosz A, Zakikhany K, Muschiol S, Hultenby K, Lindberg G. Infection of human enteroendocrine cells with Chlamydia trachomatis: a possible model for pathogenesis in irritable bowel syndrome. Neurogastroenterol Motil 2011; 23(10):928-34.
3. Sessa R, Di Pietro M, Santino I, del Piano M, Varveri A, Dagianti A, Penco M. Chlamydia pneumoniae infection and atherosclerotic coronary disease. Am Heart J 1999; 137(6):1116-9. (Pubitemid 30040737)
4. Sessa R, Di Pietro M, Schiavoni G, Santino I, Cipriani P, Romano S, Penco M, del Piano M. Prevalence of Chlamydia pneumoniae in peripheral blood mononuclear cells in Italian patients with acute ischaemic heart disease. Atherosclerosis 2001; 159(2):521-5. (Pubitemid 33127267)
5. Sessa R, Di Pietro M, Schiavoni G, Santino I, Benedetti-Valentini F, Perna R, Romano S, del Piano M. Chlamydia pneumoniae DNA in patients with symptomatic carotid atherosclerotic disease. J Vasc Surg 2003; 37(5):1027-31. (Pubitemid 36538926)
6. Romano S, Fratini S, Di Pietro M, et al. Chlamydia pneumoniae infection in patients with acute coronary syndrome: a clinical and serological 1-year follow-up. Int J Immunopathol Pharmacol 2004; 17(2):209-18.
7. Romano S, Penco M, Fratini S, Di Pietro M, Sessa R, Del Piano M, Fedele F, Dagianti A. Chlamydia pneumoniae infection is associated with coronary artery disease but not implicated in inducing plaque instability. Int J Cardiol 2004; 95(1):95-9. (Pubitemid 38670478)
8. Sessa R, Di Pietro M, Schiavoni G, et al. Detection of Chlamydia pneumoniae in atherosclerotic coronary arteries. Int J Immunopathol Pharmacol 2004; 17:301-306. (Pubitemid 39481673)
9. Sessa R, Schiavoni G, Di Pietro M, et al. Chlamydia pneumoniae in PBMC: reproducibility of the ompA nested touchdown PCR. Int J Immunopathol Pharmacol 2005; 18:113-120. (Pubitemid 40343464)
10. Sessa R., Di Pietro M, Schiavoni G., et al. Chlamydia pneumoniae in asymptomatic carotid atherosclerosis. Int J Immunopathol Pharmacol 2006; 19:111-8.
11. Sessa R, Di Pietro M, Schiavoni G, Petrucca A, Cipriani P, Zagaglia C, Nicoletti M, Santino I, del Piano M. Measurement of Chlamydia pneumoniae bacterial load in peripheral blood mononuclear cells may be helpful to assess the state of chlamydial infection in patients with carotid atherosclerotic disease. Atherosclerosis 2007; 195(1):e224-30.
12. Sessa R, Cipriani P, Di Pietro M, Schiavoni G, Santino I, del Piano M. Chlamydia pneumoniae and chronic diseases with a great impact on public health. Int J Immunopathol Pharmacol 2008; 21(4):1041-3.
13. Di Pietro M, Schiavoni G, del Piano M, et al. Chlamydia pneumoniae and atherosclerosis: the role of mast cells. J Biol Regul Homeost Agents 2009; 23(2):65-9.
14. Sessa R, Nicoletti M, Di Pietro M, Schiavoni G, Santino I, Zagaglia C, del Piano M, Cipriani P. Chlamydia pneumoniae and atherosclerosis: current state and future prospectives. Int J Immunopathol Pharmacol 2009; 22(1):9-14.
15. Sessa R, Di Pietro M, Schiavoni G, et al. Chlamydia pneumoniae induces T cell apoptosis through glutathione redox imbalance and secretion of TNF-alpha. Int J Immunopathol Pharmacol 2009; 22(3):659-68.
16. Schiavoni G, Di Pietro M, Ronco C, et al. Chlamydia pneumoniae infection as a risk factor for accelerated atherosclerosis in hemodialysis patients. J Biol Regul Homeost Agents 2010; 24(3):367-75.
17. Di Pietro M, Schiavoni G, Sessa V, Pallotta F, Costanzo G, Sessa R. Chlamydia pneumoniae and osteoporosis associated bone loss: a new risk factor? Osteoporos Int 2012. In press (DOI 10.1007/ s00198-012-2217-1).
18. Collina F, De Chiara A, De Renzo A, De Rosa G, Botti G, Franco R. Chlamydia psittaci in ocular adnexa MALT lymphoma: a possible role in lymphomagenesis and a different geographical distribution. Infect Agent Cancer 2012; 7:8.
19. McCoy AJ, Maurelli AT. Building the invisible wall: updating the chlamydial peptidoglycan anomaly. Trends Microbiol 2006; 14(2):70-7. (Pubitemid 43190736)
20. Pavelka MS Jr. Another brick in the wall. Trends Microbiol 2007; 15(4):147-9.
21. Ghuysen JM, Goffin C. Lack of cell wall peptidoglycan versus penicillin sensitivity: new insights into the chlamydial anomaly. Antimicrob Agents Chemother 1999; 43(10):2339-44. (Pubitemid 29471206)
22. Brown WJ, Rockey DD. Identification of an antigen localized to an apparent septum within dividing chlamydiae. Infect Immun 2000; 68(2):708-15. (Pubitemid 30056527)
23. Opitz B, Förster S, Hocke AC, Maass M, Schmeck B, Hippenstiel S, Suttorp N, Krüll M. Nod1-mediated endothelial cell activation by Chlamydophila pneumoniae. Circ Res 2005; 96(3):319-26. (Pubitemid 40279906)
24. Welter-Stahl L, Ojcius DM, Viala J, et al. Stimulation of the cytosolic receptor for peptidoglycan, Nod1, by infection with Chlamydia trachomatis or Chlamydia muridarum. Cell Microbiol 2006; 8(6):1047-57. (Pubitemid 43670843)
25. McCoy AJ, Adams NE, Hudson AO, Gilvarg C, Leustek T, Maurelli AT. L,L-diaminopimelate aminotransferase, a trans-kingdom enzyme shared by Chlamydia and plants for synthesis of diaminopimelate/lysine. Proc Natl Acad Sci USA 2006; 103(47):17909-14. (Pubitemid 44852259)
26. Watanabe N, Clay MD, van Belkum MJ, Fan C, Vederas JC, James MN. The structure of LL-diaminopimelate aminotransferase from Chlamydia trachomatis: implications for its broad substrate specificity. J Mol Biol 2011; 411(3):649-60.
27. Di Pietro M, Tramonti A, De Santis F, De Biase D, Schiavoni G, Filardo S, Zagaglia C, Sessa R. Analysis of gene expression in penicillin G induced persistence of Chlamydia pneumoniae. J Biol Regul Homeost Agents 2012; 26(2):277-84.
28. Mäurer AP, Mehlitz A, Mollenkopf HJ, Meyer TF. Gene expression profiles of Chlamydophila pneumoniae during the developmental cycle and iron depletion-mediated persistence. PLoS Pathog 2007; 3(6):e83.
29. Belland RJ, Nelson DE, Virok D, Crane DD, Hogan D, Sturdevant D, Beatty WL, Caldwell HD. Transcriptome analysis of chlamydial growth during IFN-gamma-mediated persistence and reactivation. Proc Natl Acad Sci USA 2003; 100(26):15971-6. (Pubitemid 38021099)